Synvista Therapeutics, Inc. (SYNI)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Dec 30, 2025
Synvista Therapeutics Market Cap
Synvista Therapeutics has a market cap or net worth of $3 as of September 24, 2026. Its market cap has decreased by -98.84% in one year.
Market Cap
3.00
Enterprise Value
n/a
Revenue
54.73K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since November 1, 1991, Synvista Therapeutics's market cap has decreased from 330.80M to 3.00, a decrease of -100.00%. That is a compound annual growth rate of -41.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 3.00 | - |
| Dec 30, 2020 | 3.00 | -88.46% |
| Dec 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 825.89M |
| Silence Therapeutics | 739.97M |
| Nika Pharmaceuticals | 431.19M |
| American Oncology Network | 371.06M |
| Panbela Therapeutics | 5.00 |
| Assure Holdings | 4.00 |
| Ormand Industries | 4.00 |
| Biocept | 3.00 |